Abstract
Multimodal imaging using nanomaterials in a single platform will bring hopeful for patients, and provide exact information including the tumor location and size for doctors. Herein, we synthesize reduced graphene oxide-manganese ferrite (RGO-MnFe2O4) nanocomposites via a hydrothermal reaction, and modify nanocomposites with polyethylene glycol (PEG) to improve its biocompatibility. Interestingly, PEGylated RGO-MnFe2O4 nanocomposites possess excellent T1/T2 weighted magnetic resonance imaging (MRI) of mice bearing 4T1 tumor after intravenous (i.v.) injection. After additional radioisotope labeling, SPECT imaging of 125I labeled RGO-MnFe2O4-PEG nanocomposites exhibit high tumor accumulation. Under the guidance of MRI/SPECT imaging, in vivo combined radioisotope therapy (RIT) and chemotherapy is carried out using anticancer drug doxorubicin and 131I co-loaded RGO-MnFe2O4-PEG nanocomposites, significant inhibiting the tumor growth after intravenous injection. Moreover, 131I- RGO-MnFe2O4-PEG/DOX nanocomposites cause no obvious toxicity to treated mice after 60 days post injection. Our study further promote the biomedical applications of nano-graphene based nanocomposites.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
